CS166850B2 - - Google Patents
Info
- Publication number
- CS166850B2 CS166850B2 CS7848A CS784873A CS166850B2 CS 166850 B2 CS166850 B2 CS 166850B2 CS 7848 A CS7848 A CS 7848A CS 784873 A CS784873 A CS 784873A CS 166850 B2 CS166850 B2 CS 166850B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
- C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
- C07J1/0025—Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0003—Androstane derivatives
- C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2257132A DE2257132C3 (de) | 1972-11-18 | 1972-11-18 | Verfahren zur Reduktion von 3-Ketosteroiden |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS166850B2 true CS166850B2 (en:Method) | 1976-03-29 |
Family
ID=5862375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS7848A CS166850B2 (en:Method) | 1972-11-18 | 1973-11-15 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US3875195A (en:Method) |
| JP (1) | JPS5710879B2 (en:Method) |
| CH (1) | CH586237A5 (en:Method) |
| CS (1) | CS166850B2 (en:Method) |
| DD (1) | DD108080A5 (en:Method) |
| DE (1) | DE2257132C3 (en:Method) |
| DK (1) | DK134782C (en:Method) |
| FR (1) | FR2207129A1 (en:Method) |
| GB (1) | GB1455578A (en:Method) |
| HU (1) | HU166940B (en:Method) |
| NL (1) | NL7315781A (en:Method) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4031117A (en) * | 1975-09-22 | 1977-06-21 | Becton, Dickinson And Company | Testosterone derivatives |
| JPS60135171U (ja) * | 1984-02-20 | 1985-09-07 | 株式会社エバニュ− | ロ−ラ−スケ−トの車輪 |
| JPS60135172U (ja) * | 1984-02-20 | 1985-09-07 | 株式会社エバニュ− | ロ−ラ−スケ−トの車輪 |
| ES2041245T3 (es) * | 1985-10-23 | 1993-11-16 | The Upjohn Company | Esteroides angioestaticos. |
| JPH01130377U (en:Method) * | 1988-02-24 | 1989-09-05 | ||
| TWI334781B (en) * | 2002-10-28 | 2010-12-21 | Phytopharm Plc | Stereospecific synthesis of sapogenins |
-
1972
- 1972-11-18 DE DE2257132A patent/DE2257132C3/de not_active Expired
-
1973
- 1973-11-14 DD DD174637A patent/DD108080A5/xx unknown
- 1973-11-14 CH CH1599673A patent/CH586237A5/xx not_active IP Right Cessation
- 1973-11-15 US US416095A patent/US3875195A/en not_active Expired - Lifetime
- 1973-11-15 CS CS7848A patent/CS166850B2/cs unknown
- 1973-11-15 DK DK618373A patent/DK134782C/da active
- 1973-11-16 HU HUSCHE452*1A patent/HU166940B/hu unknown
- 1973-11-16 JP JP12908973A patent/JPS5710879B2/ja not_active Expired
- 1973-11-16 NL NL7315781A patent/NL7315781A/xx not_active Application Discontinuation
- 1973-11-16 FR FR7340869A patent/FR2207129A1/fr not_active Withdrawn
- 1973-11-19 GB GB5364273A patent/GB1455578A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7315781A (en:Method) | 1974-05-21 |
| DK134782B (da) | 1977-01-17 |
| US3875195A (en) | 1975-04-01 |
| JPS4981360A (en:Method) | 1974-08-06 |
| DE2257132A1 (de) | 1974-05-30 |
| HU166940B (en:Method) | 1975-06-28 |
| DE2257132B2 (de) | 1981-07-23 |
| CH586237A5 (en:Method) | 1977-03-31 |
| FR2207129A1 (en:Method) | 1974-06-14 |
| DD108080A5 (en:Method) | 1974-09-05 |
| DK134782C (da) | 1977-06-06 |
| JPS5710879B2 (en:Method) | 1982-03-01 |
| GB1455578A (en) | 1976-11-17 |
| DE2257132C3 (de) | 1982-05-13 |